Cargando…
Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator
BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries. The polymorphism rs10490924 in the ARMS2 gene is highly associated with AMD and linked to an indel mutation (del443ins54), the latter inducing mRNA instability. At present, the function of th...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234120/ https://www.ncbi.nlm.nih.gov/pubmed/28086806 http://dx.doi.org/10.1186/s12974-016-0776-3 |
_version_ | 1782494943473827840 |
---|---|
author | Micklisch, Sven Lin, Yuchen Jacob, Saskia Karlstetter, Marcus Dannhausen, Katharina Dasari, Prasad von der Heide, Monika Dahse, Hans-Martin Schmölz, Lisa Grassmann, Felix Alene, Medhanie Fauser, Sascha Neumann, Harald Lorkowski, Stefan Pauly, Diana Weber, Bernhard H. Joussen, Antonia M. Langmann, Thomas Zipfel, Peter F. Skerka, Christine |
author_facet | Micklisch, Sven Lin, Yuchen Jacob, Saskia Karlstetter, Marcus Dannhausen, Katharina Dasari, Prasad von der Heide, Monika Dahse, Hans-Martin Schmölz, Lisa Grassmann, Felix Alene, Medhanie Fauser, Sascha Neumann, Harald Lorkowski, Stefan Pauly, Diana Weber, Bernhard H. Joussen, Antonia M. Langmann, Thomas Zipfel, Peter F. Skerka, Christine |
author_sort | Micklisch, Sven |
collection | PubMed |
description | BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries. The polymorphism rs10490924 in the ARMS2 gene is highly associated with AMD and linked to an indel mutation (del443ins54), the latter inducing mRNA instability. At present, the function of the ARMS2 protein, the exact cellular sources in the retina and the biological consequences of the rs10490924 polymorphism are unclear. METHODS: Recombinant ARMS2 was expressed in Pichia pastoris, and protein functions were studied regarding cell surface binding and complement activation in human serum using fluoresence-activated cell sorting (FACS) as well as laser scanning microscopy (LSM). Biolayer interferometry defined protein interactions. Furthermore, endogenous ARMS2 gene expression was studied in human blood derived monocytes and in human induced pluripotent stem cell-derived microglia (iPSdM) by PCR and LSM. The ARMS2 protein was localized in human genotyped retinal sections and in purified monocytes derived from AMD patients without the ARMS2 risk variant by LSM. ARMS2 expression in monocytes under oxidative stress was determined by Western blot analysis. RESULTS: Here, we demonstrate for the first time that ARMS2 functions as surface complement regulator. Recombinant ARMS2 binds to human apoptotic and necrotic cells and initiates complement activation by recruiting the complement activator properdin. ARMS2-properdin complexes augment C3b surface opsonization for phagocytosis. We also demonstrate for the first time expression of ARMS2 in human monocytes especially under oxidative stress and in microglia cells of the human retina. The ARMS2 protein is absent in monocytes and also in microglia cells, derived from patients homozygous for the ARMS2 AMD risk variant (rs10490924). CONCLUSIONS: ARMS2 is likely involved in complement-mediated clearance of cellular debris. As AMD patients present with accumulated proteins and lipids on Bruch’s membrane, ARMS2 protein deficiency due to the genetic risk variant might be involved in drusen formation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0776-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5234120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52341202017-01-17 Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator Micklisch, Sven Lin, Yuchen Jacob, Saskia Karlstetter, Marcus Dannhausen, Katharina Dasari, Prasad von der Heide, Monika Dahse, Hans-Martin Schmölz, Lisa Grassmann, Felix Alene, Medhanie Fauser, Sascha Neumann, Harald Lorkowski, Stefan Pauly, Diana Weber, Bernhard H. Joussen, Antonia M. Langmann, Thomas Zipfel, Peter F. Skerka, Christine J Neuroinflammation Research BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries. The polymorphism rs10490924 in the ARMS2 gene is highly associated with AMD and linked to an indel mutation (del443ins54), the latter inducing mRNA instability. At present, the function of the ARMS2 protein, the exact cellular sources in the retina and the biological consequences of the rs10490924 polymorphism are unclear. METHODS: Recombinant ARMS2 was expressed in Pichia pastoris, and protein functions were studied regarding cell surface binding and complement activation in human serum using fluoresence-activated cell sorting (FACS) as well as laser scanning microscopy (LSM). Biolayer interferometry defined protein interactions. Furthermore, endogenous ARMS2 gene expression was studied in human blood derived monocytes and in human induced pluripotent stem cell-derived microglia (iPSdM) by PCR and LSM. The ARMS2 protein was localized in human genotyped retinal sections and in purified monocytes derived from AMD patients without the ARMS2 risk variant by LSM. ARMS2 expression in monocytes under oxidative stress was determined by Western blot analysis. RESULTS: Here, we demonstrate for the first time that ARMS2 functions as surface complement regulator. Recombinant ARMS2 binds to human apoptotic and necrotic cells and initiates complement activation by recruiting the complement activator properdin. ARMS2-properdin complexes augment C3b surface opsonization for phagocytosis. We also demonstrate for the first time expression of ARMS2 in human monocytes especially under oxidative stress and in microglia cells of the human retina. The ARMS2 protein is absent in monocytes and also in microglia cells, derived from patients homozygous for the ARMS2 AMD risk variant (rs10490924). CONCLUSIONS: ARMS2 is likely involved in complement-mediated clearance of cellular debris. As AMD patients present with accumulated proteins and lipids on Bruch’s membrane, ARMS2 protein deficiency due to the genetic risk variant might be involved in drusen formation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0776-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-05 /pmc/articles/PMC5234120/ /pubmed/28086806 http://dx.doi.org/10.1186/s12974-016-0776-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Micklisch, Sven Lin, Yuchen Jacob, Saskia Karlstetter, Marcus Dannhausen, Katharina Dasari, Prasad von der Heide, Monika Dahse, Hans-Martin Schmölz, Lisa Grassmann, Felix Alene, Medhanie Fauser, Sascha Neumann, Harald Lorkowski, Stefan Pauly, Diana Weber, Bernhard H. Joussen, Antonia M. Langmann, Thomas Zipfel, Peter F. Skerka, Christine Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
title | Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
title_full | Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
title_fullStr | Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
title_full_unstemmed | Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
title_short | Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
title_sort | age-related macular degeneration associated polymorphism rs10490924 in arms2 results in deficiency of a complement activator |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234120/ https://www.ncbi.nlm.nih.gov/pubmed/28086806 http://dx.doi.org/10.1186/s12974-016-0776-3 |
work_keys_str_mv | AT micklischsven agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT linyuchen agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT jacobsaskia agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT karlstettermarcus agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT dannhausenkatharina agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT dasariprasad agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT vonderheidemonika agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT dahsehansmartin agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT schmolzlisa agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT grassmannfelix agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT alenemedhanie agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT fausersascha agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT neumannharald agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT lorkowskistefan agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT paulydiana agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT weberbernhardh agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT joussenantoniam agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT langmannthomas agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT zipfelpeterf agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator AT skerkachristine agerelatedmaculardegenerationassociatedpolymorphismrs10490924inarms2resultsindeficiencyofacomplementactivator |